|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fan LM, Strasser-Weippl KM, Li JM, St
Louis JB, Finkelstein DMP, Yu KM, Chen WM, Shao ZM and Goss PEP:
Breast cancer in China. Lancet Oncol. 15:e279–e289. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Akram M, Iqbal M, Daniyal M and Khan AU:
Awareness and current knowledge of breast cancer. Biol Res.
50:332017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu X, Liu Y, Du Y, Cheng T and Xia W: Long
non-coding RNA BLACAT1 promotes breast cancer cell proliferation
and metastasis by miR-150-5p/CCR2. Cell Biosci. 9:142019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang Y, Du F, Chen F, Qin N, Jiang Z,
Zhou J, Jiang T, Pu Z, Cheng Y, Chen J, et al: Potentially
functional variants in lncRNAs are associated with breast cancer
risk in a Chinese population. Mol Carcinogen. 56:2048–2057. 2017.
View Article : Google Scholar
|
|
6
|
Liu Y, Sharma S and Watabe K: Roles of
lncRNA in breast cancer. Front Biosci (Schol Ed). 7:94–108. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Niknafs YS, Han S, Ma T, Speers C, Zhang
C, Wilder-Romans K, Iyer MK, Pitchiaya S, Malik R, Hosono Y, et al:
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1
in breast cancer progression. Nat Commun. 7:127912016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song P, Jiang B, Liu Z, Ding J, Liu S and
Guan W: A three-lncRNA expression signature associated with the
prognosis of gastric cancer patients. Cancer Med. 6:1154–1164.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li J, Han L, Roebuck P, Diao L, Liu L,
Yuan Y, Weinstein JN and Liang H: TANRIC: An interactive open
platform to explore the function of lncRNAs in cancer. Cancer Res.
75:3728–3737. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep. 8:92272018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cancer Genome Atlas Network: Comprehensive
molecular portraits of human breast tumours. Nature. 490:61–70.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pathan M, Keerthikumar S, Ang C, Gangoda
L, Quek CYJ, Williamson NA, Mouradov D, Sieber OM, Simpson RJ,
Salim A, et al: FunRich: An open access standalone functional
enrichment and interaction network analysis tool. Proteomics.
15:2597–2601. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42((Database Issue)): D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dongre A and Weinberg RA: New insights
into the mechanisms of epithelial-mesenchymal transition and
implications for cancer. Nat Rev Mol Cell Biol. 20:69–84. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Voutsadakis I: Epithelial-Mesenchymal
Transition (EMT) and regulation of EMT factors by steroid nuclear
receptors in breast cancer: A review and in silico
investigation. J Clin Med. 5(pii): E112016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Balemans W and Van Hul W: Extracellular
regulation of BMP signaling in vertebrates: A cocktail of
modulators. Dev Biol. 250:231–250. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Attisano L and Wrana JL: Signal
transduction by members of the transforming growth factor-beta
superfamily. Cytokine Growth Factor Rev. 7:327–339. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cyr-Depauw C, Northey JJ, Tabariès S,
Annis MG, Dong Z, Cory S, Hallett M, Rennhack JP, Andrechek ER and
Siegel PM: Chordin-like 1 suppresses bone morphogenetic protein
4-induced breast cancer cell migration and invasion. Mol Cell Biol.
36:1509–1525. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pei YF, Zhang YJ, Lei Y, Wu DW, Ma TH and
Liu XQ: Hypermethylation of the CHRDL1 promoter induces
proliferation and metastasis by activating Akt and Erk in gastric
cancer. Oncotarget. 8:23155–23166. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang M, Wang Q, Yuan W, Yang S, Wang X,
Yan J, Du J, Yin J, Gao SY, Sun BC and Zhu TH: Epigenetic
regulation of bone morphogenetic protein-6 gene expression in
breast cancer cells. J Steroid Biochem Mol Biol. 105:91–97. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hamdy FC, Autzen P, Robinson MC, Horne CH,
Neal DE and Robson CN: Immunolocalization and messenger RNA
expression of bone morphogenetic protein-6 in human benign and
malignant prostatic tissue. Cancer Res. 57:4427–4431.
1997.PubMed/NCBI
|
|
25
|
Maki DD and Grossman RI: Patterns of
disease spread in metastatic breast carcinoma: Influence of
estrogen and progesterone receptor status. Am J Neuroradiol.
21:1064–1066. 2000.PubMed/NCBI
|
|
26
|
Mekala JR, Naushad SM, Ponnusamy L,
Arivazhagan G, Sakthiprasad V and Pal-Bhadra M: Epigenetic
regulation of miR-200 as the potential strategy for the therapy
against triple-negative breast cancer. Gene. 641:248–258. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ning X, Shi Z, Liu X, Zhang A, Han L,
Jiang K, Kang C and Zhang Q: DNMT1 and EZH2 mediated methylation
silences the microRNA-200b/a/429 gene and promotes tumor
progression. Cancer Lett. 359:198–205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang G, Zhang W, Li B, Stringer-Reasor E,
Chu C, Sun L, Bae S, Chen D, Wei S, Jiao K, et al: MicroRNA-200c
and microRNA-141 are regulated by a FOXP3-KAT2B axis and associated
with tumor metastasis in breast cancer. Breast Cancer Res.
19:732017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
